Citrus aurantium patents
This article was originally published in The Tan Sheet
Executive SummaryPatent & Trademark Office issues three patents to Zhishin for Advantra Z citrus aurantium extract for weight loss, physical performance, according to Nutratech, the ingredient's exclusive worldwide licensee. Patented claims include "increasing the ratio of lean muscle to total body mass," "improving athletic performance" and "suppressing appetite," in addition to earlier patented claim for "stimulating thermogenesis and reducing weight." Advantra Z is found in USANA, Natrol and Twinlab products; ingredient soon will appear in NBTY supplements as well. Acknowledging presence of other, potentially infringing citrus aurantium products on market, Nutratech says it will take any "necessary action" to protect its intellectual property rights...
You may also be interested in...
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.
Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug; FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.
FerGene bladder cancer therapy achieved a complete response in more than half of patients in its pivotal trial. The joint venture now looks to commercialization and potential expansion of indications.